Literature DB >> 2854305

Molecular basis for the heterogeneity of human tyrosinase.

S Shibahara1, Y Tomita, H Tagami, R M Müller, T Cohen.   

Abstract

A cDNA clone, pHT gamma 1, representing human tyrosinase mRNA was isolated by screening a melanoma cDNA library with a synthetic oligonucleotide complementary to a segment of the human tyrosinase cDNA, Pmel 34 [Kwon et al. (1987) Proc. nat. Acad. Sci. USA 84, 7473-7477]. However, there are a number of differences in the nucleotide sequence between two cDNAs, pHT gamma 1 and Pmel 34, particularly in the region coding for the carboxyl terminus of the enzyme (putative exon 5). We therefore cloned the genomic DNA segment carrying the exon 5 of the human tyrosinase gene by screening a human placental genomic DNA library with a cloned cDNA probe. The nucleotide sequences of human tyrosinase cDNA as well as part of its gene were determined. Mature human tyrosinase is composed of 511 amino acids with a molecular weight of 58,000. We provide evidence for the presence of at least two species of human tyrosinase mRNA generated by alternative splicing in human pigmented melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2854305     DOI: 10.1620/tjem.156.403

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  15 in total

1.  A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosinase-negative oculocutaneous albinism.

Authors:  C D Chintamaneni; R Halaban; Y Kobayashi; C J Witkop; B S Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

2.  A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.

Authors:  L B Giebel; M A Musarella; R A Spritz
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

3.  Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.

Authors:  W S Oetting; M M Mentink; C G Summers; R A Lewis; J G White; R A King
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

4.  A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.

Authors:  L B Giebel; K M Strunk; R A King; J M Hanifin; R A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  High efficiency liposome-mediated transfection of the tyrosinase gene to cultured cells: a model for the gene therapy of hair color restoration.

Authors:  L Li; V Lishko; R M Hoffman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

6.  Molecular analyses of a tyrosinase-negative albino family.

Authors:  K C Park; C D Chintamaneni; R Halaban; C J Witkop; B S Kwon
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

7.  Di-leucine signals mediate targeting of tyrosinase and synaptotagmin to synaptic-like microvesicles within PC12 cells.

Authors:  A D Blagoveshchenskaya; E W Hewitt; D F Cutler
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

8.  Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis.

Authors:  Akira Hachiya; Akemi Kobayashi; Yasuko Yoshida; Takashi Kitahara; Yoshinori Takema; Genji Imokawa
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.

Authors:  K Yasumoto; K Yokoyama; K Shibata; Y Tomita; S Shibahara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.

Authors:  R Gershoni-Baruch; A Rosenmann; S Droetto; S Holmes; R K Tripathi; R A Spritz
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.